# Feasibility Study of Lidocaine Infusion During Bowel Cancer Surgery for Cancer Outcome

> **NCT05250791** · NA · UNKNOWN · sponsor: **Imperial College London** · enrollment: 50 (estimated)

## Conditions studied

- Colorectal Cancer
- Quality of Life
- Recurrent Cancer

## Interventions

- **DRUG:** Lidocaine hydrochloride 2% for injection
- **DRUG:** 0.9% sterile Sodium Chloride solution for injection

## Key facts

- **NCT ID:** NCT05250791
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-02
- **Primary completion:** 2024-09-15
- **Final completion:** 2024-09-15
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05250791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05250791, "Feasibility Study of Lidocaine Infusion During Bowel Cancer Surgery for Cancer Outcome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05250791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*